ArticleClinical cancer research : an official journal of the American Association for Cancer Research2021

Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912).

Jennifer H Foster et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.